Alison M. Bidgood

Penetration of GS4071, a novel influenza neuraminidase inhibitor, into rat bronchoalveolar lining fluid following oral administration of the prodrug GS4104

Eugene Eisenberg, Alison M. Bidgood, K C Cundy · Antimicrobial Agents and Chemotherapy · 1997 · 86 citations · Full text

Pharmaceutical Science, Oral Bioavailability, Medicine +12

Pharmacokinetics, bioavailability, metabolism, and tissue distribution of cidofovir (HPMPC) and cyclic HPMPC in rats.

K C Cundy, Alison M. Bidgood, Geoffrey Lynch et al. · Drug Metabolism and Disposition · 1996 · 67 citations

Pharmacokinetics and metabolism of selected prodrugs of PMEA in rats.

Jing-Ping Shaw, Michael S. Louie, V. V. Krishnamurthy et al. · PubMed · 1997 · 54 citations

Oral Bioavailability, Pharmacokinetic Modeling, Biochemistry +14

Metabolism of the Influenza Neuraminidase Inhibitor Prodrug Oseltamivir in the Rat

David J. Sweeny, Geoffrey Lynch, Alison M. Bidgood et al. · Drug Metabolism and Disposition · 2000 · 40 citations

Preclinical Characterization of GS-9669, a Thumb Site II Inhibitor of the Hepatitis C Virus NS5B Polymerase

Martijn Fenaux, Stacey Eng, Stephanie A. Leavitt et al. · Antimicrobial Agents and Chemotherapy · 2012 · 40 citations · Full text